John Childs Insider Profile
18 Followers
John Childs, Director at Biohaven Ltd., holds 2.20M shares in Veradermics, Incorporated (Ticker: MANE), holds 9.88M shares in Biohaven Ltd. (Ticker: BHVN), holds 1.52M shares in Biohaven Pharmaceutical Holding Co (Ticker: ~BHVN).
Profitable Transactions
15 out of 24 Profitable Transactions
Average Return
+28.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Childs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 05, 2026 - Today
Return:+182.50%
The most profitable trade made by John Childs
John Childs's Trading History
Biohaven Ltd.
Nov 17, 2025
Director
Informative Buy
25.00M
$133.34M
Veradermics, Incorporated
Feb 05, 2026
Director
Uninformative Buy
―
$231.21M
Mattress Firm
Sep 16, 2016
―
Uninformative Sell
870.35M
$834.45M
Biohaven Pharmaceutical Holding Co
Oct 05, 2022
―
Informative Buy
2.46M
$231.06M
List of latest transactions for each holding click on a transaction to see John Childs's performance on stock
You May Also Like
John Childs insider profile FAQ
What is the percentage of profitable transactions made by John Childs?
The percentage of profitable transactions made by John Childs is 63%.
What is the average return per transaction made by John Childs?
The average return per transaction made by John Childs is 28.80%.
What stocks does John Childs hold?
John Childs holds: BHVN, MANE, MFRM, ~BHVN stocks.
What was John Childs’s latest transaction?
John Childs latest transaction was an Uninformative Buy of ―.
What was John Childs's most profitable transaction?
John Childs’s most profitable transaction was an Informative Buy of MANE stock on February 5, 2026. The return on the trade was 182.50%.
What is John Childs's role in Biohaven Ltd.?
John Childs's role in Biohaven Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.